The surgical robotics space has never been more competitive - with three large strategics vying for share in the soft tissue segment of the market. Medtronic recently secured regulatory clearance for ...

Residential Assistants United Rising (RAUR — a student group advocating for the unionization of Resident Assistants (RAs) at Stanford — received a union election date of Oct. 6 and 7 following a ...

Anurag is an experienced journalist and author who’s been covering tech for the past 5 years, with a focus on Windows, Android, and Apple. He’s written for sites like Android Police, Neowin, Dexerto, ...

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...

Anthropic, OpenAI, Meta and Google all released model updates this week as the pace of new releases continues to accelerate. "We are in an environment where there's just so much frothiness that you ...

Most AI tools allow you to opt out of sharing your usage with the model provider to improve future versions. Meta has taken that idea and put a price tag on it. For its new Muse Spark model, intended ...

The biotech revealed at ASCO that daraxonrasib doubled progression-free survival, a result that led a massive conference audience to rise to their feet in applause. (Darren Incorvaia) Following ...

The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...

The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...

Nvidia published some interesting new research on Friday suggesting it’s the harness, more than the underlying model, that is far more important when asking an AI to do long-horizon tasks. A harness ...